Key points are not available for this paper at this time.
Our findings provide novel evidence supporting the bidirectional relationship between the gut microbiota and ALS. These results may contribute to designing microbiome- and microbiome-dependent metabolite interventions in future ALS clinical trials.
Zhang et al. (Mon,) studied this question.